XML 76 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Assets    
Unrestricted cash and cash equivalents $ 60,957 $ 67,915
Restricted cash and cash equivalents 15,017 12,921
Loans and fees receivable:    
Loans and fees receivable, net (of $9,496 and $8,274 in deferred revenue and $13,606 and $11,151 in allowances for uncollectible loans and fees receivable at June 30, 2013 and December 31, 2012, respectively) 76,418 69,625
Loans and fees receivable, at fair value 15,662 20,378
Loans and fees receivable pledged as collateral under structured financings, at fair value 107,258 133,595
Property at cost, net of depreciation 7,725 7,192
Investments in equity-method investees 38,636 37,756
Deposits 16,197 16,397
Prepaid expenses and other assets 13,560 14,647
Total assets 351,430 380,426
Liabilities    
Accounts payable and accrued expenses 34,726 38,596
Notes payable, at face value 42,017 26,747
Notes payable associated with structured financings, at fair value 113,613 140,127
Convertible senior notes 95,628 95,335
Income tax liability 61,036 60,434
Total liabilities 347,020 361,239
Commitments and contingencies (Note 10)      
Equity    
Common stock, no par value, 150,000,000 shares authorized: 15,444,580 shares issued and outstanding (including 1,672,656 loaned shares to be returned) at June 30, 2013; and 15,509,179 shares issued and outstanding (including 1,672,656 loaned shares to be returned) at December 31, 2012 0 0
Additional paid-in capital 210,468 211,122
Accumulated other comprehensive loss (2,526) (1,154)
Retained deficit (203,530) (190,673)
Total shareholders’ equity 4,412 19,295
Noncontrolling interests (2) (108)
Total equity 4,410 19,187
Total liabilities and equity $ 351,430 $ 380,426